Virve Vaeisaenen

Title: The Innovative Contributions of Virve Vaeisaenen

Introduction

Virve Vaeisaenen is a notable inventor based in Veikkola, Finland. She has made significant strides in the field of cardiovascular diagnostics. Her work focuses on the use of ceramides and lysophospholipids in predicting cardiovascular events.

Latest Patents

Virve Vaeisaenen holds a patent for the invention titled "Use of ceramides and LPLs in diagnosing CVD." This invention provides a method for predicting cardiovascular events such as acute myocardial infarction, acute coronary syndrome, stroke, and cardiovascular death. The method involves determining the concentration of specific ceramides and lysophospholipids in a biological sample and comparing these concentrations to a control. An increased concentration of certain ceramides or lysophospholipids indicates a higher risk of developing cardiovascular events. Additionally, the patent includes methods for diagnosing subjects suffering from acute ischemia, along with kits and compositions for predicting and diagnosing cardiovascular events.

Career Highlights

Virve Vaeisaenen is associated with Zora Biosciences Oy, where she continues to contribute to innovative research in the field of cardiovascular health. Her work has the potential to significantly impact the way cardiovascular diseases are diagnosed and managed.

Collaborations

Virve collaborates with notable colleagues, including Mika Hilvo and Reini Hurme, who contribute to her research efforts and innovations.

Conclusion

Virve Vaeisaenen's contributions to the field of cardiovascular diagnostics through her innovative patent demonstrate her commitment to advancing medical science. Her work not only enhances our understanding of cardiovascular risks but also paves the way for improved diagnostic methods.